跳至主要内容
临床试验/CTRI/2024/10/074564
CTRI/2024/10/074564尚未招募不适用

An observational study to explore the outcome of multimodal Ayurveda treatment in the management of chronic kidney disease-A prospective cohort study

All India Institute Of Ayurveda1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2024年10月9日最近更新:

试验速览

阶段
不适用
状态
尚未招募
入组人数
30
试验地点
1
主要终点
Changes in the Renal function test and clinical symptoms of CKD after observing for 12weeks

研究概览

简要总结

Chronic Kidney Disease(CKD) is worldwide threat to public health and multiply risk on major non-communicable diseases, including CVD , DM Type 1 & 2 . However , with ageing CKD become a leading cause of mortality. In India, the  annual prevalence of CKD is 800 per million population (pmp), and the incidence of end-stage renal disease (ESRD) is 150–200 pmp. with majority of the patients requiring hemodialysis and transplant, this poses significant financial burden over the affected families with approximately 146% unable to afford medical bills. . Inspite of treatment, there is significant reduction in the quality of the life of the patients. thus, increasing number of patients resort to AYUSH systems of medicine for care. The present study is an effort to document the outcomes of Ayurveda clinical practice in the management of CKD, both in terms of objective and subjective parameters. this will serve as a reference for developing future hypothesis for conducting large scale clinical trials.

研究设计

研究类型
Observational

入排标准

年龄范围
21.00 Year(s) 至 65.00 Year(s)(—)
性别
All

入选标准

  • 1.Diagnosed cases of CKD with classical signs and symptoms.
  • 2.According to International Classification of Disease 11th Revision (ICD-11) guidelines:- GB61 Chronic kidney disease GB61.0 Chronic kidney disease, stage 1 GB61.1 Chronic kidney disease, stage 2 GB61.2 Chronic kidney disease, stage 3a GB61.3 Chronic kidney disease, stage 3b GB61.4 Chronic kidney disease, stage 4 GB61.5 Chronic kidney disease, stage 5.

排除标准

  • 1.Patients present with complain of Tuberculosis, Carcinoma ,Pregnant and lactating mother.
  • 2.Patient with Hepatorenal Syndrome.
  • 3.Patient with uncontrolled Diabetes Mellitus and Hypertension.
  • 4.Patient with Ischemic heart disease and other conditions which may become an outliers due to differed response.

结局指标

主要结局

Changes in the Renal function test and clinical symptoms of CKD after observing for 12weeks

时间窗: day0 | day15 | day30 | day45 | day60 | day75 | day90

次要结局

  • 1. Changes in the Quality of life, after observing for 12weeks.(2. Come up with the draft suggesting the trend of present clinical practice in CKD and further may help for developing a protocol.)

研究者

申办方类型
Government medical college
责任方
Principal Investigator
主要研究者

Anuradha

All India Institute Of Ayurveda

研究点 (1)

Loading locations...

相似试验

Exploring the outcome of Combined Ayurvedic... | 临床试验